Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy.

@article{Mitler2000LongtermEA,
  title={Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy.},
  author={Mitler and Harsh and Hirshkowitz and Guilleminault},
  journal={Sleep medicine},
  year={2000},
  volume={1 3},
  pages={231-243}
}
Objectives: To assess the long-term efficacy and safety of modafinil in patients with excessive daytime sleepiness (EDS) associated with narcolepsy.Background: Modafinil has been shown to be effective and well tolerated for treating EDS associated with narcolepsy in two large-scale, well-controlled, 9-week clinical trials.Methods: Four hundred and seventy eight adult patients with a diagnosis of narcolepsy who had completed one of two 9-week, double-blind, placebo-controlled, multicenter… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

Correlating behaviour and gene expression endpoints in the dopaminergic system after modafinil administration in mouse.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology • 2016
View 2 Excerpts

Quality measures for the care of patients with narcolepsy.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine • 2015

Synthesis and psychobiological evaluation of modafinil analogs in mice

DARU Journal of Pharmaceutical Sciences • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…